Accumulating evidence indicates that MALAT1 serves as a pivotal determinant in diagnosing metastatic potential across various malignancies [29], exhibiting notably elevated expression in recurrent colorectal cancer [30] and metastatic lesions [31]. This evidence concerns the gene MALAT1 and colorectal cancer.